martes, 25 de junio de 2019

CF Children Ages 6 to 11 Can Now Access Symdeko After FDA Approval

CF Children Ages 6 to 11 Can Now Access Symdeko After FDA Approval

Cystic Fibrosis News Today

FDA Approves Symdeko for Treatment of CF Children, Ages 6 to 11, with Certain CFTR Mutations

 JUNE 25, 2019
Joana CarvalhoBY JOANA CARVALHO
 
IN NEWS.
FDA Approves Symdeko for Treatment of CF Children, Ages 6 to 11, with Certain CFTR Mutations
en

No hay comentarios:

Publicar un comentario